- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.02. | Report says Jim O'Neill's time at HHS is nearing its end | ||
| 13.02. | Bankruptcy threat looms as Quince runs out of options | ||
| 13.02. | Lundbeck preps phase 3 for migraine prevention drug | ||
| 13.02. | PTC pulls file for Duchenne therapy on FDA feedback | ||
| 13.02. | ILiAD bags $115m for pertussis vaccine, and other financings | ||
| 12.02. | BridgeBio gains on phase 3 dwarfism data | ||
| 12.02. | Euro VCs team up to invigorate life sciences ecosystem | ||
| 12.02. | Zydus follows Lupin with Myrbetriq settlement deal | ||
| 12.02. | FDA says comparator dose scuppered Moderna's flu jab filing | ||
| 12.02. | Hudson out at Sanofi, as Belén Garijo named CEO | ||
| 11.02. | Madrigal builds in MASH with $4.4bn+ Ribo alliance | ||
| 11.02. | Inept digital interaction undermining pharma with clinicians | ||
| 11.02. | Novo Nordisk's Wegovy pill ad 'misleading', says FDA | ||
| 11.02. | Moderna cries foul as FDA blocks filing of mRNA flu shot | ||
| 11.02. | UK moves ahead with GP patient data sharing plan | ||
| 10.02. | FDA kicks off review of Takeda's narcolepsy hopeful | ||
| 10.02. | Kailera, Hengrui stake claim to oral weight loss category | ||
| 10.02. | AstraZeneca raises guidance on stellar cancer drugs growth | ||
| 10.02. | Takeda signs $1.7bn AI alliance with Iambic | ||
| 10.02. | Dismay as FDA blocks Regenxbio's Hunter syndrome therapy | ||
| 10.02. | Lupin settles Myrbetriq patent spat with Astellas for $90m | ||
| 09.02. | Lilly strikes again, buying CAR-T firm Orna for $2.4bn | ||
| 09.02. | Data builds on Roche's dominance in primary progressive MS | ||
| 09.02. | Novartis breaks ground on San Diego biomedical R&D site | ||
| 09.02. | Lilly strikes $8.8bn-plus alliance with China's Innovent |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.